Synthesis, characterization, and biological activity of Co(II) and Zn(II) complexes of imidazoles-based azo-functionalized Schiff bases

被引:16
|
作者
Mahdy, Ahmed R. E. [1 ]
Abu Ali, Ola A. [2 ]
Serag, Waleed M. [3 ]
Fayad, Eman [4 ]
Elshaarawy, Reda F. M. [3 ,5 ]
Gad, Emad M. [6 ]
机构
[1] Port Said Univ, Fac Sci, Dept Chem, Port Said 42526, Egypt
[2] Taif Univ, Coll Sci, Dept Chem, POB 11099, Taif 21944, Saudi Arabia
[3] Suez Univ, Fac Sci, Dept Chem, Suez 43533, Egypt
[4] Taif Univ, Fac Sci, Dept Biotechnol, POB 11099, Taif 21944, Saudi Arabia
[5] Heinrich Heine Univ Dusseldorf, Inst Anorgan Chem & Strukturchem, Dusseldorf, Germany
[6] Suez Canal Univ, Fac Sci, Chem Dept, Ismailia, Egypt
关键词
Azo-functionalized Schiff bases; Imidazoles; Co(II)/Zn(II) complexes; Flow-cytometry; Cytotoxicity; BINDING; DNA;
D O I
10.1016/j.molstruc.2022.132726
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
A new series of azo-functionalized Schiff base ligands containing different imidazole derivatives (HL1- HL3) and their Co(II)/Zn(II) complexes were successfully prepared. The molecular structures of the new ligands and their metal complexes have been deduced using microanalytical and spectral techniques. The thermal stability study revealed that the Co(II)/Zn(II) complexes are more stable than their corresponding ligands. The results of in vitro cytotoxicity test revealed that all compounds have the capacity to inhibit the growth of breast carcinoma (MCF-7) cells with a structure-dependent performance. Among all, complex CoL3, (IC50 = 0.90 +/- 0.05 mu g/mL) was the most potent and selective (SI = 90.56) anti-breast cancer agent. Flow-cytometric study revealed that CoL3 dramatically enhanced the proportion of MCF-7 cells in the sub G1 phase while decreasing the proportion of cells in the S phase. In addition, CoL3 showed better inhibitory activity on DNA topoisomerase-II. (c) 2022 Elsevier B.V. All rights reserved.
引用
收藏
页数:10
相关论文
共 50 条